FA
GILD icon

Fagan Associates’s Gilead Sciences GILD Stock Holding History

Fagan Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,532
Closed -$214K – 140
2026
Q1 		$214K Buy
+1,532
New +$215K 0.03% 130
2023
Q4 		– Sell
-6,515
Closed -$488K – 114
2023
Q3 		$488K Buy
6,515
+770
+13% +$59.2K 0.12% 82
2023
Q2 		$443K Buy
5,745
+600
+12% +$47.9K 0.11% 85
2023
Q1 		$427K Buy
5,145
+1,679
+48% +$139K 0.11% 92
2022
Q4 		$298K Buy
+3,466
New +$274K 0.08% 104
2018
Q1 		– Sell
-34,594
Closed -$2.48M – 105
2017
Q4 		$2.48M Buy
34,594
+155
+0.5% +$11.8K 1% 30
2017
Q3 		$2.79M Buy
34,439
+1,364
+4% +$104K 1.38% 26
2017
Q2 		$2.34M Buy
33,075
+845
+3% +$56.2K 1.22% 30
2017
Q1 		$2.19M Sell
32,230
-870
-3% -$61.2K 1.21% 28
2016
Q4 		$2.37M Buy
33,100
+320
+1% +$23.8K 1.37% 26
2016
Q3 		$2.59M Sell
32,780
-5,385
-14% -$437K 1.59% 23
2016
Q2 		$3.18M Buy
+38,165
New +$3.39M 2.05% 16
2015
Q3 		– Sell
-62,655
Closed -$7.34M – 92
2015
Q2 		$7.34M Buy
+62,655
New +$6.85M 4.89% 2
2014
Q2 		– Sell
-64,835
Closed -$4.59M – 89
2014
Q1 		$4.59M Buy
+64,835
New +$5.08M 3.98% 4

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fagan Associates's GILD Position: Q2 2026 in Review

Fagan Associates sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,532 shares — an estimated $214K sold.

Fagan Associates first reported a position in GILD in Q1 2014 and held it in 14 quarters. The position peaked at $7.34M in Q2 2015. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fagan Associates reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Fagan Associates sold 1,532 Gilead Sciences shares in Q2 2026, an estimated $214K.
  • Fagan Associates first reported a position in Gilead Sciences in Q1 2014 and held it in 14 quarters.
  • Fagan Associates's Gilead Sciences position peaked at $7.34M in Q2 2015.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fagan Associates's 13F filing for Q2 2026, filed 4 Aug 2026.